Privia Health Group, Inc. financial data

Symbol
PRVA on Nasdaq
Location
Arlington, VA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 169% % -6.7%
Debt-to-equity 78% % 6.5%
Return On Equity 3.1% % 39%
Return On Assets 1.8% % 35%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 123,688,289 shares 1.5%
Common Stock, Shares, Outstanding 123,604,576 shares 2.7%
Entity Public Float $1,750,000,000 USD 64%
Common Stock, Value, Issued $1,236,000 USD 2.7%
Weighted Average Number of Shares Outstanding, Basic 122,176,587 shares 2.3%
Weighted Average Number of Shares Outstanding, Diluted 128,889,836 shares 2.6%

Income Statement

Label TTM Value / Value Unit Change %
Selling and Marketing Expense $27,136,000 USD 2.6%
General and Administrative Expense $138,152,000 USD 9.5%
Operating Income (Loss) $34,235,000 USD 102%
Nonoperating Income (Expense) $9,703,000 USD -11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $43,938,000 USD 58%
Income Tax Expense (Benefit) $14,212,000 USD 31%
Net Income (Loss) Attributable to Parent $22,919,000 USD 59%
Earnings Per Share, Basic 0.19 USD/shares 58%
Earnings Per Share, Diluted 0.18 USD/shares 64%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $479,685,000 USD -2.3%
Accounts Receivable, after Allowance for Credit Loss, Current $400,902,000 USD 27%
Assets, Current $911,001,000 USD 9.1%
Deferred Income Tax Assets, Net $2,274,000 USD -91%
Property, Plant and Equipment, Net $504,000 USD -59%
Operating Lease, Right-of-Use Asset $8,794,000 USD 82%
Goodwill $209,842,000 USD 48%
Other Assets, Noncurrent $21,044,000 USD 23%
Assets $1,369,378,000 USD 21%
Accounts Payable, Current $7,973,000 USD -18%
Liabilities, Current $568,520,000 USD 27%
Operating Lease, Liability, Noncurrent $7,331,000 USD 141%
Other Liabilities, Noncurrent $2,584,000 USD 1589%
Liabilities $578,435,000 USD 28%
Retained Earnings (Accumulated Deficit) $156,310,000 USD 13%
Stockholders' Equity Attributable to Parent $737,217,000 USD 16%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $790,943,000 USD 16%
Liabilities and Equity $1,369,378,000 USD 21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $24,061,000 USD 27%
Net Cash Provided by (Used in) Financing Activities $2,243,000 USD 372%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 123,604,576 shares 2.7%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $21,818,000 USD 43%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $479,685,000 USD -2.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $0 USD
Deferred Tax Assets, Gross $30,501,000 USD -16%
Operating Lease, Liability $9,531,000 USD 71%
Depreciation $228,000 USD -22%
Lessee, Operating Lease, Liability, to be Paid $10,611,000 USD 83%
Property, Plant and Equipment, Gross $8,048,000 USD 0%
Operating Lease, Liability, Current $2,200,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,196,000 USD 25%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,141,000 USD -11%
Operating Lease, Weighted Average Discount Rate, Percent 0.039 pure 50%
Deferred Income Tax Expense (Benefit) $1,713,000 USD 98%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,080,000 USD 419%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,874,000 USD 130%
Deferred Tax Assets, Operating Loss Carryforwards $6,896,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,681,000 USD 321%
Additional Paid in Capital $892,291,000 USD 9.7%
Amortization of Intangible Assets $9,168,000 USD 49%
Depreciation, Depletion and Amortization $9,907,000 USD 36%
Deferred Tax Assets, Net of Valuation Allowance $30,501,000 USD -16%
Share-based Payment Arrangement, Expense $71,068,000 USD 25%